Tumor Grafting
Tumor Grafting - Related Videos
02:24
Chick Chorioallantoic Membrane Harvest: A Method to Isolate Tumor Graft-bearing Chorioallantoic Membrane from Chicken Egg
0 Views •
2023
This video demonstrates the isolation of tumor-bearing chorioallantoic membrane from the chicken embryo. The harvested CAM can be used for further downstream applications.
06:53
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
0 Views •
Cited by 14 •
2020
Bone metastasis models do not develop metastasis uniformly or with a 100% incidence. Direct intra-osseous tumor cell injection can result in embolization of the lung. We present our technique modeling primary bone tumors and bone metastasis using solid tumor graft implantation into bone, leading to reproducible engraftment and growth.
07:37
Mouse Models for Graft Arteriosclerosis
0 Views •
Cited by 17 •
2013
We describe protocols for our mouse graft arteriosclerois (GA) models which involve interposition of a mouse vessel segment into a recipient of the same inbred strain. By backcrossing additional genetic changes into the vessel donor, the model can assess the effect of specific genes on GA.
03:35
A Technique for Human Skin Grafting in a Mouse Model
0 Views •
2025
This video demonstrates a method for grafting human skin onto an immunodeficient mouse with a suppressed neutrophil response. The method involves applying human split-thickness skin to the mouse's graft bed, sealing it, and covering it for recovery. Eventually, the human skin adheres to the mouse's skin, establishing vascularization and circulation, resulting in a successful skin xenograft.
05:47
Isolation and Transplantation of Different Aged Murine Thymic Grafts.
0 Views •
Cited by 14 •
2015
This report provides a detailed description of transplanting murine thymi from different aged donor mice under the kidney capsule of immunodeficient mouse recipients. The goal of this approach is to model T cell development and thymic selection events in vivo.
FAQs
The labels describe the relationship between the tumor donor and the host: syngeneic, allogeneic, or xenogeneic grafts use different donor-recipient pairings. That relationship is a central model-selection variable because it determines how the implanted tumor is categorized in vivo. Comparing these graft types lets cancer researchers choose a system aligned with the biological question being studied.
Successful graft survival depends on more than the presence of transplanted tumor cells or tissue. The graft must adapt to its new setting, interact with the host microenvironment, and develop vascular support. These linked processes influence whether the tumor persists and grows, making host-tumor interactions an important mechanistic focus in cancer research.
Vascular development matters because it supplies the graft with nutrients and oxygen after implantation. This support is part of the biological transition from transplanted material to a tumor that can be studied in vivo. Examining vascular development helps researchers interpret graft persistence and growth in relation to the host environment rather than treating tumor cells as an isolated system.
A study begins by selecting tumor cells or tissue and defining the donor-host relationship, then transplanting the material into a living host. Following implantation, investigators examine whether the graft adapts, interacts with the host microenvironment, develops vascular support, and shows tumor growth. This workflow connects the implantation event with in vivo biological outcomes.
Tumor grafting supports in vivo analysis of tumor biology, treatment response, drug efficacy, and resistance. Because the tumor remains within a living host, the approach can connect therapeutic effects with changes in tumor growth and host interactions. It therefore serves as a preclinical strategy for comparing how tumors respond to candidate treatments.
Patient-derived grafts can help retain features of individual tumors, making them useful when researchers need a model that reflects patient-specific tumor characteristics. Their value lies in supporting comparison among available preclinical systems and informing which model is most appropriate for a planned cancer study, particularly when tumor biology or treatment response is the focus.